Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PLERIXAFOR safely and effectively. See full prescribing information for PLERIXAFOR. PLERIXAFOR injection, for subcutaneous use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Plerixafor is indicated in combination with filgrastim to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).
- generic_name
- plerixafor
- product_names
- PLERIXAFOR
- ndc
- 65219-284, 65219-284-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en